Colon Cancer Diagnostic Tests Market - Global Opportunity Analysis and Industry Forecast, 2019-2026

Diagnostics and Biotech	LI_184867	Pages: NA	Dec 2019 \| 465 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

CHAPTER 4 COLON CANCER DIAGNOSTIC TESTS MARKET, BY TEST

4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. FECAL OCCULT BLOOD TESTS (FOBT)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Guaiac FOB stool test
4.2.4.1. Market size and forecast
4.2.5. Immuno-FOB ELISA test
4.2.5.1. Market size and forecast
4.3. BIOMARKER TESTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. DNA based biomarkers test
4.3.4.1. Market size and forecast
4.3.5. Protein based biomarkers test
4.3.5.1. Market size and forecast
4.3.6. Metabolite based biomarkers test
4.3.6.1. Market size and forecast

CHAPTER 5 COLON CANCER DIAGNOSTIC TESTS MARKET, BY END USER

5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS
5.2.1. Market size and forecast
5.3. CLINICAL DIAGNOSTIC LABORATORIES
5.3.1. Market size and forecast
5.4. PHYSICIANS’ OFFICE LABORATORIES
5.4.1. Market size and forecast
5.5. HOME TEST KIT
5.5.1. Market size and forecast

CHAPTER 6 COLON CANCER DIAGNOSTIC TESTS MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. North America Colon Cancer Diagnostic Tests Market by Country
6.2.3.1. U.S.
6.2.3.1.1. U.S. Colon Cancer Diagnostic Tests Market by Test
6.2.3.1.2. U.S. Colon Cancer Diagnostic Tests Market by End User
6.2.3.2. Canada
6.2.3.2.1. Canada Colon Cancer Diagnostic Tests Market by Test
6.2.3.2.2. Canada Colon Cancer Diagnostic Tests Market by End User
6.2.3.3. Mexico
6.2.3.3.1. Mexico Colon Cancer Diagnostic Tests Market by Test
6.2.3.3.2. Mexico Colon Cancer Diagnostic Tests Market by End User
6.2.4. North America Colon Cancer Diagnostic Tests Market by Test
6.2.5. North America Colon Cancer Diagnostic Tests Market by End User
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Europe Colon Cancer Diagnostic Tests Market by Country
6.3.3.1. Germany
6.3.3.1.1. Germany Colon Cancer Diagnostic Tests Market by Test
6.3.3.1.2. Germany Colon Cancer Diagnostic Tests Market by End User
6.3.3.2. France
6.3.3.2.1. France Colon Cancer Diagnostic Tests Market by Test
6.3.3.2.2. France Colon Cancer Diagnostic Tests Market by End User
6.3.3.3. UK
6.3.3.3.1. UK Colon Cancer Diagnostic Tests Market by Test
6.3.3.3.2. UK Colon Cancer Diagnostic Tests Market by End User
6.3.3.4. Italy
6.3.3.4.1. Italy Colon Cancer Diagnostic Tests Market by Test
6.3.3.4.2. Italy Colon Cancer Diagnostic Tests Market by End User
6.3.3.5. Spain
6.3.3.5.1. Spain Colon Cancer Diagnostic Tests Market by Test
6.3.3.5.2. Spain Colon Cancer Diagnostic Tests Market by End User
6.3.3.6. Rest of Europe
6.3.3.6.1. Rest of Europe Colon Cancer Diagnostic Tests Market by Test
6.3.3.6.2. Rest of Europe Colon Cancer Diagnostic Tests Market by End User
6.3.4. Europe Colon Cancer Diagnostic Tests Market by Test
6.3.5. Europe Colon Cancer Diagnostic Tests Market by End User
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Asia-Pacific Colon Cancer Diagnostic Tests Market by Country
6.4.3.1. Japan
6.4.3.1.1. Japan Colon Cancer Diagnostic Tests Market by Test
6.4.3.1.2. Japan Colon Cancer Diagnostic Tests Market by End User
6.4.3.2. China
6.4.3.2.1. China Colon Cancer Diagnostic Tests Market by Test
6.4.3.2.2. China Colon Cancer Diagnostic Tests Market by End User
6.4.3.3. Australia
6.4.3.3.1. Australia Colon Cancer Diagnostic Tests Market by Test
6.4.3.3.2. Australia Colon Cancer Diagnostic Tests Market by End User
6.4.3.4. India
6.4.3.4.1. India Colon Cancer Diagnostic Tests Market by Test
6.4.3.4.2. India Colon Cancer Diagnostic Tests Market by End User
6.4.3.5. South Korea
6.4.3.5.1. South Korea Colon Cancer Diagnostic Tests Market by Test
6.4.3.5.2. South Korea Colon Cancer Diagnostic Tests Market by End User
6.4.3.6. Rest of Asia-Pacific
6.4.3.6.1. Rest of Asia-Pacific Colon Cancer Diagnostic Tests Market by Test
6.4.3.6.2. Rest of Asia-Pacific Colon Cancer Diagnostic Tests Market by End User
6.4.4. Asia-Pacific Colon Cancer Diagnostic Tests Market by Test
6.4.5. Asia-Pacific Colon Cancer Diagnostic Tests Market by End User
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. LAMEA Colon Cancer Diagnostic Tests Market by Country
6.5.3.1. Brazil
6.5.3.1.1. Brazil Colon Cancer Diagnostic Tests Market by Test
6.5.3.1.2. Brazil Colon Cancer Diagnostic Tests Market by End User
6.5.3.2. Saudi Arabia
6.5.3.2.1. Saudi Arabia Colon Cancer Diagnostic Tests Market by Test
6.5.3.2.2. Saudi Arabia Colon Cancer Diagnostic Tests Market by End User
6.5.3.3. South Africa
6.5.3.3.1. South Africa Colon Cancer Diagnostic Tests Market by Test
6.5.3.3.2. South Africa Colon Cancer Diagnostic Tests Market by End User
6.5.3.4. Rest of LAMEA
6.5.3.4.1. Rest of LAMEA Colon Cancer Diagnostic Tests Market by Test
6.5.3.4.2. Rest of LAMEA Colon Cancer Diagnostic Tests Market by End User
6.5.4. LAMEA Colon Cancer Diagnostic Tests Market by Test
6.5.5. LAMEA Colon Cancer Diagnostic Tests Market by End User

CHAPTER 7 COMPANY PROFILES

7.1. QUIDEL CORPORATION
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. EIKEN CHEMICAL CO., LTD.
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. EPIGENOMICS AG
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. BECKMAN COULTER, INC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. ABBOTT LABORATORIES
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. BIOHIT OYJ.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. POLYMEDCO CDP, LLC
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. QUEST DIAGNOSTICS INCORPORATED
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. RANDOX LABORATORIES LTD.
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. EDP BIOTECH
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,110 Data Pack/Excel ~~$3,840~~ $3,456 Single User License ~~$5,370~~ $4,833 Five User License ~~$6,450~~ $5,805 Enterprise User License ~~$8,995~~ $8,096

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com